UPDATE (1:15 p.m. PT) — Oregon has received its first shipments of remdesivir, an experimental antiviral drug that has been used to treat patients hospitalized with severe cases of COVID-19.

According to the Oregon Health Authority, the drug hasn’t been formally approved by the Food and Drug Administration, but is being used under a federally approved emergency use authorization.

The authorization allows health professionals to administer the drug to severely ill COVID-19 patients who meet certain clinical criteria. 

Preliminary clinical testing by the National Institute of Allergy and Infectious Diseases showed that some patients treated with the drug recovered up to 31% faster. According to Gilead Sciences Inc., the drug’s developer, “it is not known if remdesivir is safe and effective for the treatment of COVID-19.”

The Oregon Health Authority is

Read More At Article Source | Article Attribution